SEC Form D private-offering filing

Paulex Bio Inc.

Name: Paulex Bio Inc. - new SEC Form D private-offering filing, La Jolla, CA
Published: 2025-12-18

A new SEC Form D private-offering notice from La Jolla, CA, a $22,500,000 filer-stated offering target in Biotech. The source filing is one click away.

Paulex Bio Inc. site↗ Verified via SEC Form D

Paulex Bio develops an oral regenerative medicine designed to restore insulin producing beta cells to treat type 1 and type 2 diabetes.

Filed 2025-12-18Filed to raise $22,500,000First money in 2025-11-21Raised so far $18,516,040HQ (as filed) La Jolla, CASector Biotech ✓Stage (inferred) EarlyCall status Delayed filing

Source linked the Form D on EDGAR↗Website verified paulexbio.com↗Named in the filing 4 executives & directors

Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.